M Rottmann1, T Beck2, A Burges3, C Dannecker3, M Kiechle4, D Mayr5, A Schlesinger-Raab6, G Schubert-Fritschle6, J Engel6. 1. Munich Cancer Registry (MCR) of the Munich Tumour Centre (TZM), Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), University Hospital of Munich, Klinikum Großhadern, Ludwig-Maximilians-Universität (LMU), Marchioninistr. 15, 81377, Munich, Germany. rottmann@ibe.med.uni-muenchen.de. 2. Department of Gynaecology, RoMed Hospital Rosenheim, Rosenheim, Germany. 3. Department of Obstetrics and Gynaecology, University Hospital of Munich, Ludwig-Maximilians-Universität (LMU), Munich, Germany. 4. Department of Obstetrics and Gynaecology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany. 5. Department of Pathology, University Hospital of Munich, Ludwig-Maximilians-Universität (LMU), Munich, Germany. 6. Munich Cancer Registry (MCR) of the Munich Tumour Centre (TZM), Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), University Hospital of Munich, Klinikum Großhadern, Ludwig-Maximilians-Universität (LMU), Marchioninistr. 15, 81377, Munich, Germany.
Abstract
PURPOSE: The objective was to identify trends in surgery and the outcomes of squamous cell vulvar cancer in a population-based setting. METHODS: A total of 1113 patients with squamous cell vulvar cancer diagnosed between 1998 and 2013 in the catchment area of the Munich Cancer Registry (population approximately 4.6 million) were analysed. Trends in prognostic factors and treatment were examined by comparing patients diagnosed between 1998 and 2008 with those diagnosed between 2009 and 2013. Cumulative incidence was used to calculate time to local (LR) and lymph node recurrence (LNR). Survival was analysed by the Kaplan-Meier method, calculation of relative survival (RS), and a Cox model. RESULTS: The high median age at diagnosis of 75 years did not change significantly over time. In addition, no changes in the subsite of tumour or grading were noted. A decrease in patients undergoing complete vulvectomy from 27.7 to 17.8 % (p < 0.001) as well as an increase in the use of sentinel lymph node biopsy from 11.4 to 39.1 % (p < 0.001) was observed. However, time to LR (from 19 to 19 %) and time to LNR (from 9 to 9 %) as well as 5-year overall survival (from 55 to 55 %) and RS (from 66 to 63 %) were not significantly altered. After adjustment for prognostic factors, less radical locoregional surgery had no influence on survival. CONCLUSION: Less radical locoregional surgery in vulvar cancer is increasingly implemented. Locoregional recurrence and survival have not been affected by these changes and are likely accompanied by an improvement in quality of life.
PURPOSE: The objective was to identify trends in surgery and the outcomes of squamous cell vulvar cancer in a population-based setting. METHODS: A total of 1113 patients with squamous cell vulvar cancer diagnosed between 1998 and 2013 in the catchment area of the Munich Cancer Registry (population approximately 4.6 million) were analysed. Trends in prognostic factors and treatment were examined by comparing patients diagnosed between 1998 and 2008 with those diagnosed between 2009 and 2013. Cumulative incidence was used to calculate time to local (LR) and lymph node recurrence (LNR). Survival was analysed by the Kaplan-Meier method, calculation of relative survival (RS), and a Cox model. RESULTS: The high median age at diagnosis of 75 years did not change significantly over time. In addition, no changes in the subsite of tumour or grading were noted. A decrease in patients undergoing complete vulvectomy from 27.7 to 17.8 % (p < 0.001) as well as an increase in the use of sentinel lymph node biopsy from 11.4 to 39.1 % (p < 0.001) was observed. However, time to LR (from 19 to 19 %) and time to LNR (from 9 to 9 %) as well as 5-year overall survival (from 55 to 55 %) and RS (from 66 to 63 %) were not significantly altered. After adjustment for prognostic factors, less radical locoregional surgery had no influence on survival. CONCLUSION: Less radical locoregional surgery in vulvar cancer is increasingly implemented. Locoregional recurrence and survival have not been affected by these changes and are likely accompanied by an improvement in quality of life.
Entities:
Keywords:
Cancer epidemiology; Cancer registry; Surgery; Survival; Vulvar cancer
Authors: Katina Robison; Dario Roque; Carolyn McCourt; Ashley Stuckey; Paul A DiSilvestro; C James Sung; Margaret Steinhoff; C O Granai; Richard G Moore Journal: Gynecol Oncol Date: 2014-03-11 Impact factor: 5.482
Authors: Brian M Slomovitz; Robert L Coleman; Maaike H M Oonk; Ate van der Zee; Charles Levenback Journal: Gynecol Oncol Date: 2015-05-27 Impact factor: 5.482
Authors: V Günther; B Malchow; M Schubert; L Andresen; A Jochens; W Jonat; C Mundhenke; I Alkatout Journal: Eur J Surg Oncol Date: 2014-04-03 Impact factor: 4.424
Authors: Nina Buttmann-Schweiger; Stefanie J Klug; Alexander Luyten; Bernd Holleczek; Florian Heitz; Andreas du Bois; Klaus Kraywinkel Journal: PLoS One Date: 2015-05-28 Impact factor: 3.240
Authors: Sven Mahner; Julia Jueckstock; Felix Hilpert; Petra Neuser; Philipp Harter; Nikolaus de Gregorio; Annette Hasenburg; Jalid Sehouli; Annika Habermann; Peter Hillemanns; Sophie Fuerst; Hans-Georg Strauss; Klaus Baumann; Falk Thiel; Alexander Mustea; Werner Meier; Andreas du Bois; Lis-Femke Griebel; Linn Woelber Journal: J Natl Cancer Inst Date: 2015-01-24 Impact factor: 13.506
Authors: Gabriele Schubert-Fritschle; Stephanie E Combs; Thomas Kirchner; Volkmar Nüssler; Jutta Engel Journal: Front Oncol Date: 2017-09-29 Impact factor: 6.244
Authors: David Roder; Margaret Davy; Sid Selva-Nayagam; Sellvakumaram Paramasivam; Jacqui Adams; Dorothy Keefe; Ian Olver; Caroline Miller; Elizabeth Buckley; Kate Powell; Kellie Fusco; Dianne Buranyi-Trevarton; Martin K Oehler Journal: BMC Cancer Date: 2018-08-30 Impact factor: 4.430